Cargando…
An antigen self-assembled and dendritic cell-targeted nanovaccine for enhanced immunity against cancer
The rise of nanotechnology has opened new horizons for cancer immunotherapy. However, most nanovaccines fabricated with nanomaterials suffer from carrier-related concerns, including low drug loading capacity, unpredictable metabolism, and potential systemic toxicity, which bring obstacles for their...
Autores principales: | Zhang, Yunting, Jiang, Min, Du, Guangsheng, Zhong, Xiaofang, He, Chunting, Qin, Ming, Hou, Yingying, Liu, Rong, Sun, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465870/ https://www.ncbi.nlm.nih.gov/pubmed/37655327 http://dx.doi.org/10.1016/j.apsb.2022.03.017 |
Ejemplares similares
-
Recent progress in application of nanovaccines for enhancing mucosal immune responses
por: Du, Guangsheng, et al.
Publicado: (2023) -
Self-Assembled, Adjuvant/Antigen-Based Nanovaccine Mediates Anti-Tumor Immune Response against Melanoma Tumor
por: Rajendrakumar, Santhosh Kalash, et al.
Publicado: (2018) -
The pore size of mesoporous silica nanoparticles regulates their antigen delivery efficiency
por: Hong, Xiaoyu, et al.
Publicado: (2020) -
Self-Assembling Nanovaccine Enhances Protective Efficacy Against CSFV in Pigs
por: Liu, Ze-Hui, et al.
Publicado: (2021) -
Designing self-assembled peptide nanovaccine against Streptococcus pneumoniae: An in silico strategy
por: Dorosti, Hesam, et al.
Publicado: (2019)